SEARCH

SEARCH BY CITATION

References

  • AGHAJANIAN, G.K. (1978). Tolerance of locus coeruleus neurons to morphine and suppression of withdrawal response by clonidine. Nature, 276, 186188.
  • ALREJA, M. & AGHAJANIAN, G.K. (1993). Opiates suppress a resting sodiumd-ependent inward current and activate an outward potassium current in locus coeruleus neurons. J. Neurosci., 13, 35253532.
  • ALREJA, M. & AGHAJANIAN, G.K. (1995). Intracellular application of macromolecules through patch pipettes in brain slices. In Brain Slices in Basic and Clinical Research. eds. Schurr, A. & Riger, B.M. pp. 117130. London: CRC Press.
  • ARICIOGLU-KARTAL, F. & UZBAY, T. (1997). Inhibitory effect of agmatine on naloxone-precipitated abstinence syndrome in morphine dependent rats. Life Sci., 61, 17751781.
  • BARROT, M., RETTORI, M.C., GUARDIOLA-LEMAITRE, B., JARRY, C., LE MOAL, M. & PIAZZA, P.V. (2000). Interactions between imidazoline binding sites and dopamine levels in the rat nucleus accumbens. Eur. J. Neurosci., 12, 45474551.
  • BORONAT, M.A., OLMOS, G. & GARCIA-SEVILLA, J.A. (1998). Attenuation of tolerance to opioid-induced antinociception and protection against morphine-induced decrease of neurofilament proteins by idazoxan and other I2-imidazoline ligands. Br. J. Pharmacol., 125, 175185.
  • CHAN, S.L.F., DUNNE, M.J., STILLINGS, M.R. & MORGAN, N.G. (1991). The α2-adrenoceptor antagonist efaroxan modulates K+ATP? channels in insulin-secreting cells. Eur. J. Pharmacol., 204, 4148.
  • EGLEN, R.M., HUDSON, A.L., KENDALL, D.A., NUTT, D.J., MORGAN, N.G., WILSON, V.G. & DILLON, M.P. (1998). Seeing through a glass darkly: casting light on imidazoline I sites. Trends Pharmacol. Sci., 19, 381390.
  • FAIRBANKS, C.A. & WILCOX, G.L. (1997). Acute tolerance to spinally administered morphine compares mechanistically with chronically induced morphine tolerance. J. Pharmacol. Exp. Ther., 282, 14081417.
  • FINTA, E.P., HARMS, L., SEVCIK, J., FISCHER, H.D. & ILLES, P. (1993). Effect of potassium channel openers and their antagonists on rat locus coeruleus neurones. Br. J. Pharmacol., 109, 308315.
  • GARCÍA-SEVILLA, J.A., ESCRIBÁ, P.V. & GUIMÓN, J. (1999). Imidazoline receptors and human brain disorders. Ann. N.Y. Acad. Sci., 881, 392409.
  • HORVÁTH, G., KEKESI, G., DOBOS, I., SZIKSZAY, M., KLIMSCHA, W. & BENEDEK, G. (1999). Effect of intrathecal agmatine on inflammation-induced thermal hyperalgesia in rats. Eur. J. Pharmacol., 368, 197204.
  • HUDSON, A.L., GOUGH, R., TYACKE, R., LIONE, L., LALIES, M., LEWIS, J., HUSBANDS, S., KNIGHT, P., MURRAY, F., HUTSON, P. & NUTT, D.J. (1999). Novel selective compounds for the investigation of imidazoline receptors. Ann. N.Y. Acad. Sci., 88, 8191.
  • INANOBE, A. & KURACHI, Y. (2000). G proteingated K+ channels. In Pharmacology of ionic channel function. eds. Makato, E., Yoshihisa, K. & Masaayoshi, M. pp. 297331. Berlin: Springer-Verlag.
  • KOLESNIKOV, Y., JAIN, S. & PASTERNAK, G.W. (1996). Modulation of opioid analgesia by agmatine. Eur. J. Pharmacol., 296, 1722.
  • LIONE, L.A., NUTT, D.J. & HUDSON, A.L. (1996). [3H]2-(2-benzofuranyl)-2-imidazoline: a new selective high affinity radioligand for the study of rabbit brain imidazoline I2 receptors. Eur. J. Pharmacol., 304, 221229.
  • LIONE, L.A., NUTT, D.J. & HUDSON, A.L. (1998). Characterization and localization of [3H]2-(2-benzofuranyl)-2-imidazoline binding in rat brain: a selective ligand for imidazoline I2 receptors. Eur. J. Pharmacol., 353, 123135.
  • MALDONADO, R. & KOOB, G.F. (1993). Destruction of the locus coeruleus decreases physical sing of opiate withdrawal syndrome. J. Pharmacol. Exp. Ther., 261, 669677.
  • MELICHAR, J.K., DAGLISH, R.C. & NUTT, D.J. (2001). Addiction and withdrawal–current views. Current Opinion Pharmacol., 1, 8490.
  • MIRALLES, A., OLMOS, G., SATRE, M., BARTUREN, F., MARTIN, I. & GARCIA-SEVILLA, J.A. (1993). Discrimination and pharmacological characterization of the I2-imidazoline sites with [3H]idazoxan and alpha-2 adrenoceptors with [3H]RX821002 (2-methoxy idazoxan) in the human and the rat brains. J. Pharmacol. Exp. Ther., 264, 11871197.
  • OLMOS, G., KULKARNI, R.N., HAQUE, M. & MACDERMOT, J. (1994). Imidazoline stimulate release of insulin from RIN-5AH cells independently from imidazoline I1 and I2 receptors. Eur. J. Pharmacol., 262, 4148.
  • OCAÑA, M., DEL POZO, E. & BAYENS, J.M. (1995). Subgroups among μ-opioid receptor agonists distinguished by ATP-sensitive K+ channel-acting drugs. Br. J. Pharmacol., 114, 12961302.
  • OZAITA, A., OLMOS, G., BORONAT, M.A., LIZCANO, J.M., UNZETA, M. & GARCÍA-SEVILLA, J.A. (1997). Inhibition of monoamine oxidase A and B activities by imidazol(ine)/guanidine drugs, nature of the interaction and distribution from I2-imidazoline receptors in rat liver. Br. J. Pharmacol., 121, 901912.
  • PARKER, R.B. & WAUD, D.R. (1971). Pharmacological estimation of drug-receptor dissociation constants. Statistical evaluation. I. Agonist. J. Pharmacol. Exp. Ther., 177, 112.
  • PAXINOS, G. & WATSON, C. (1986). The Rat Brain in Stereotaxic Coordinates. 2nd ed. Orlando: Academic Press.
  • PINEDA, J., UGEDO, L. & GARCIA-SEVILLA, J.A. (1993). Stimulatory effects of clonidine, cirazoline and rilmenidine on locus coeruleus noradrenergic neurones: possible involvement of imidazoline-preferring receptors. Naunyn-Schmiedeberg's Arch. Pharmacol., 348, 134140.
  • PINEDA, J., TORRECILLA, M., MARTIN-RUIZ, R. & UGEDO, L. (1998). Attenuation of withdrawal-induced hyperactivity of locus coeruleus neurones by inhibitors of nitric oxide synthase in morphine-dependent rats. Neuropharmacology, 37, 759767.
  • RASMUSSEN, K., BEITNER-JOHNSON, D.B., KRYSTAL, J.H., AGHAJANIAN, G.K. & NESTLER, E.J. (1990). Opiate withdrawal and the rat locus coeruleus: behavioural, electrophysiological, and biochemical correlates. J. Neurosci., 10, 23082317.
  • RUIZ-ORTEGA, J.A. & UGEDO, L. (1997). The stimulatory effect of clonidine on locus coeruleus neurons of rats with inactivated alpha 2-adrenoceptors: involvement of imidazoline receptors located in the nucleus paragigantocellularis. Naunyn Schmiedeberg's Arch. Pharmacol., 355, 288294.
  • SÁNCHEZ-BLÁZQUEZ, P., BORONAT, M.A., OLMOS, G., GARCIA-SEVILLA, J.A. & GARZON, J. (2000). Activation of I(2)-imidazoline receptors enhances supraspinal morphine analgesia in mice: a model to detect agonist and antagonist activities at these receptors. Br. J. Pharmacol., 130, 146152.
  • SASTRE, M., VENTAYOL, P. & GARCÍA-SEVILLA, J.A. (1996). Decreased density of I2 imidazoline receptors in the post-mortem brains of heroin addicts. NeuroReport, 7, 509512.
  • SASTRE-COLL, A., ESTEBAN, S., MIRALLES, A., ZANETTI, R. & GARCÍASEVILLA, J.A. (2001). The imidazoline receptor ligand 2-(2-benzofuranyl)-2-imidazoline is a dopamine-releasing agent in the rat striatum in vivo. Neurosci. Lett., 301, 2932.
  • UGEDO, L., PINEDA, J., RUIZ-ORTEGA, J.A. & & MARTIN-RUIZ, R. (1998). Stimulation of locus coeruleus neurons by non-I1/I2-type imidazoline receptors: an in vivo and in vitro electrophysiological study. Br. J. Pharmacol., 125, 16851694.
  • UGEDO, L., PINEDA, J., MARTIN-RUIZ, R., RUIZ-ORTEGA, J.A., MARTINRUIZ, R. & ARTIGAS, F. (1999). Imidazoline-induced inhibition of firing rate of 5-HT neurons in rat dorsal raphe by modulation of extracellular 5-HT levels. Ann. N. Y. Acad. Sci., 88, 365369.
  • WILLIAMS, J.T. & NORTH, R.A. (1984). Opiate-receptor interactions on single locus coeruleus neurones. Mol. Pharmacol., 26, 489497.
  • YESILYURT, O. & UZBAY, I.T. (2001). Agmatine potentiates the analgesic effect of morphine by an alpha(2)-adrenoceptor-mediated mechanism in mice. Neuropsychopharmacology, 25, 98103.